Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 254-260

  Junquera, Félix ^a   Saperas, Esteban ^a   Videla, Sebastián ^a   Feu, Faust ^b   Vilaseca, Jaime ^a   Armengol, José Ramón ^a   Bordas, Josep María ^b   Piqué, Josep María ^b   Malagelada, Juan Ramón ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; OCTREOTIDE; PANCREAS ENZYME; PLACEBO;

ABDOMINAL PAIN; AGED; ANGIODYSPLASIA; ARTICLE; BLOOD TRANSFUSION; CHOLELITHIASIS; CHOLESTASIS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HAZARD ASSESSMENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IRON THERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEVUS FLAMMEUS; PARESTHESIA; PRIORITY JOURNAL; PROBABILITY; PRURITUS; RECURRENT DISEASE; SAMPLE SIZE; STROKE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANGIODYSPLASIA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL DISEASES; MALE; OCTREOTIDE; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33846555501     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01053.x     Document Type: Article

References (29)

1. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-18.
2. Brown SG, Swain CP, Storey DW, et al. Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut 1985;26:1338-48.
3. Rutgeerts P, Van Gompel F, Geboes K, et al. Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation. Gut 1985;26:586-93.
4. Gostout CJ, Bowyer BA, Ahlquist DA, et al. Mucosal vascular malformations of the gastrointestinal tract: Clinical observations and results of endoscopic neodymium: ytrium-aluminum-Garnet laser therapy. Mayo Clin Proc 1988;63:993-1003.
5. Naveau S, Aubert A, Poynard T, et al. Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci 1990;35:821-6.
6. Marshall JK, Hunt RH. Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: A promising alternative. Eur J Gastroenterol Hepatol 1997;9:521-5.
7. Van Cutsem E, Rutgeerts P, Geboes K, et al. Estrogen-progesterone treatment of Osler-Weber-Rendu disease. J Clin Gastroenterol 1988;10:676-9.
8. Granieri R, Mazzula J, Yarborough G. Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia. Am J Gastroenterol 1988;83:556-8.
9. Moshkowitz M, Arber N, Amir N, et al. Success of estrogen-progesterone therapy in long-standing bleeding gastrointestinal angiodysplasia. Report of a case. Dis Colon Rectum 1993;36:194-6.
10. Bronner MH, Pate MB, Cunningham JT, et al. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. Ann Intern Med 1986;105:371-4.
11. Van Cutsem E. Oestrogen-progesterone: A new therapy of bleeding gastrointestinal malformations. Acta Gastroenterol Belg 1993;56:2-10.
12. Junquera F, Santos J, Saperas E, et al. Estrogen and progestagen treatment in digestive hemorrhage caused by vascular malformations. Gastroenterol Hepatol 1995;18:61-5.
13. Van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990;335:953-5.
14. Lewis BS, Salomon P, Rivera-MacMurray S, et al. Does hormonal therapy have any benefit for bleeding angiodysplasia? J Clin Gastroenterol 1992;15:99-103.
15. Junquera F, Feu F, Papo M, et al. A multicenter, randomized, controlled, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001;121:173-9.
16. Torsoli A, Annibale B, Viscardi A, et al. Treatment of bleeding due to diffuse angiodysplasia of the small intestine with the somatostatin analogue. Eur J Gastroenterol Hepatol 1991;3:785-7.
17. Andersen MR, Aasebi J. Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia. Scand J Gastroenterol 1996;31:1037-9.
18. Rossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol 1993;88:1424-7.
19. Bowers M, McNulty O, Mayne E. Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Haematol 2000;108:524-7.
20. Nardone G, Rocco A, Balzano T, et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;13:1429-36.
21. ICH Topic E9. Note for guidance on Statistical Principles for clinical trials step 4, consensus guideline, 5 Feb 1998.
22. Eriksson LS, Wahren J. Intravenous and subcutaneous administration of a long-acting somatostatin analogue: Effects on glucose metabolism and splanchnic haemodynamics in healthy subjects. Eur J Clin Invest 1989;19:213-9.
23. Eriksson LS, Brundin T, Soderlund C, et al. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987;22:919-22.
24. Buonamico P, Jensen JE, Sabbà C, et al. Octreotide blunts portal postprandial hyperemia in cirrhotic patients. Hepatology 1991;14:194.
25. Nilsson O, Wangberg B, Theodorsson E, et al. Presence of IGF-I in human midgut carcinoid tumours - an autocrine regulator of carcinoid tumour growth? Int J Cancer 1992;51:195-203.
26. Danesi R, Tacca M. Effects of octreotide on angiogenesis. In: Scarpignato C, ed. Octreotide: From basic science to clinical medicine. Basel: Karger. Prog Basic Clin Pharmacol 1996;10:234-45.
27. Danesi R, Tacca M. Effects of somatostatin analogue octreotide on angiogenesis in vitro. Metabolism 1996;45:49-50.
28. Junquera F, Saperas E, de Torres I, et al. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 1999;94:1070-6.
29. Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001;33:330-4.